Today: 22 January 2026
Subscribe
Browse Category

Pharmaceuticals News 10 January 2026 - 11 January 2026

Haleon PLC stock: HLN slips on India leadership move as earnings loom

Haleon PLC stock: HLN slips on India leadership move as earnings loom

London, Jan 11, 2026, 09:53 GMT — Market closed Haleon PLC shares slipped 1.2% to 367.5 pence on Friday after the consumer health group named Kedar Lele to lead its India Subcontinent operations and join its senior leadership. (MarketScreener) The reason this matters now is straightforward. India’s market for everyday health brands moves quickly, shifting based on distribution, pricing discipline,…
11 January 2026
····
TG Therapeutics stock slid nearly 7% Friday — what to watch next week for TGTX

TG Therapeutics stock slid nearly 7% Friday — what to watch next week for TGTX

New York, Jan 10, 2026, 21:40 (ET) — Market closed. TG Therapeutics shares fell 6.6% on Friday to close at $28.47, down $2.03, as the biotech stock swung between $28.21 and $30.83 on about 3.3 million shares. The drop leaves traders heading into a big week for healthcare stocks as the J.P. Morgan Healthcare Conference opens Monday in San Francisco.…
11 January 2026
···
Liquidia stock jumps after $148 mln Yutrepia sales update — what to watch next week

Liquidia stock jumps after $148 mln Yutrepia sales update — what to watch next week

New York, Jan 10, 2026, 19:48 EST — Market closed Shares of Liquidia Corp surged 12.9% on Friday, closing at $35.86 following a preliminary sales update on its pulmonary hypertension drug YUTREPIA. The company also reported positive cash flow in Q4. During the session, the stock hit a high of $38.07 and was trading about 1.5% higher in after-hours, per…
11 January 2026
····
Olema Pharmaceuticals stock jumps 10% into JPM conference week: what OLMA traders are watching next

Olema Pharmaceuticals stock jumps 10% into JPM conference week: what OLMA traders are watching next

New York, Jan 10, 2026, 20:48 ET — Market closed Shares of Olema Pharmaceuticals Inc (OLMA.O) jumped nearly 10% on Friday, closing at $28.08 and extending the biotech’s strong rally. The clinical-stage breast cancer drugmaker has been on a notable upswing recently. This move is crucial as next week marks a pivotal period for small and mid-cap biotech firms. Executives…
11 January 2026
···
Revolution Medicines stock in focus as Merck buyout talk hangs over RVMD into JPMorgan week

Revolution Medicines stock in focus as Merck buyout talk hangs over RVMD into JPMorgan week

New York, January 10, 2026, 20:11 EST — The market has closed. Revolution Medicines (RVMD.O) wrapped up Friday with a 10.7% gain, closing at $118.64. The cancer-drug developer remains in focus amid ongoing takeover buzz heading into next week. Shares fluctuated between $109.88 and $125.79, with roughly 20.8 million shares changing hands. Why this matters now: Dealmakers have flocked to…
11 January 2026
···
NovaBay Pharmaceuticals stock doubles as NBY volatility flares again — what to watch next

NovaBay Pharmaceuticals stock doubles as NBY volatility flares again — what to watch next

New York, January 10, 2026, 18:35 EST — Market closed Shares of NovaBay Pharmaceuticals Inc soared on Friday, closing up roughly 103% at $19.16. Over 10 million shares changed hands, market data showed. NovaBay is back on momentum screens before the next U.S. session, trading in a price range unseen for over a year. Why it matters now: NovaBay’s size…
11 January 2026
····
Novo Nordisk Class B stock rises after Amazon adds Wegovy pill — what to watch before earnings

Novo Nordisk Class B stock rises after Amazon adds Wegovy pill — what to watch before earnings

Copenhagen, Jan 10, 2026, 20:43 CET — The market has closed. Novo Nordisk A/S Class B shares (NOVOb.CO) rose 3% on Friday after Amazon Pharmacy announced it had started selling the company’s Wegovy weight-loss pill, expanding availability for U.S. patients just days following the drug’s market debut. The Copenhagen-traded stock closed at 381.45 Danish crowns. (Reuters) The launch of Amazon’s…
10 January 2026
···
Novartis AG stock stays near a 52-week high after Florida radioligand plant plan

Novartis AG stock stays near a 52-week high after Florida radioligand plant plan

Zurich, Jan 10, 2026, 20:36 CET — Market closed Novartis AG (NOVN.S) is set to open a radioligand therapy manufacturing plant in Winter Park, Florida, part of its broader $23 billion U.S. production expansion. Shares of the Swiss drugmaker ended Friday up 0.25% at 114.04 Swiss francs, just shy of their 52-week peak of 114.64. CEO Vas Narasimhan described the…
10 January 2026
····
Roche stock in focus after MediLink cancer-drug deal as investors eye Jan. 29 results

Roche stock in focus after MediLink cancer-drug deal as investors eye Jan. 29 results

ZURICH, Jan 10, 2026, 17:45 CET — Market closed Roche Holding (ROG.S) shares edged up on Friday, boosted by news that China’s MediLink Therapeutics secured another licensing deal with the Swiss pharma giant for a cancer drug candidate. Roche participation shares closed 0.4% higher at 340.80 Swiss francs on the SIX Swiss Exchange. (Medilink Therapeutics) Why it matters now: Roche…
10 January 2026
····
AbbVie stock slips into weekend after $1.3 billion charge resets guidance; JPM conference looms

AbbVie stock slips into weekend after $1.3 billion charge resets guidance; JPM conference looms

NEW YORK, January 10, 2026, 11:17 AM EST — The market has closed. Shares of AbbVie Inc slipped 1.8% to close Friday at $220.08, wrapping up a choppy session marked by shifting guidance and takeover rumors. AbbVie disclosed in a regulatory filing that it anticipates around $1.3 billion in acquired in-process research and development (IPR&D) and milestone expenses in Q4—costs…
10 January 2026
····
Johnson & Johnson stock dips on Trump drug-price deal — what to watch before Monday

Johnson & Johnson stock dips on Trump drug-price deal — what to watch before Monday

New York, January 10, 2026, 10:58 ET — Market closed Johnson & Johnson shares fell 0.7% on Friday, closing at $204.39. The company said it reached an agreement with the U.S. government to lower drug prices in exchange for exemptions from tariffs. (Reuters) The timing matters: drugmakers are heading into another round of pricing battles abroad, particularly in Europe, after…
10 January 2026
···
1 … 7 8 9 10 11 … 45

Stock Market Today

  • Nordwand Advisors Invests $5.54 Million in QXO, Vice Analysts Comment
    January 22, 2026, 9:55 AM EST. Nordwand Advisors LLC acquired 290,750 shares of QXO, Inc. (NYSE:QXO) valued at $5.54 million in Q3, per SEC Form 13F. Other firms like Cherry Creek, Seven Grand, Vanguard, Legal & General, and Brown Miller also adjusted positions. Vanguard notably increased holdings by 91% to over 47 million shares, worth $1 billion. QXO's market cap is $16.06 billion, with a recent share price drop of 4.8% to $23.82. The company reported Q3 earnings of $0.14 per share, beating estimates, but had a negative net margin of 3.81%. Analysts remain broadly positive with 'buy' ratings despite Truist and Citigroup trimming price targets slightly.
Go toTop